Postmenopausal women's hormone levels may predict breast cancer risk

10/30/2013 | U.S. News & World Report

High levels of estrogen, androgen and prolactin were associated with an increased risk of developing invasive breast cancer after menopause, U.S. researchers reported. The findings suggest that adding hormone levels to markers already routinely considered could significantly improve breast cancer risk prediction models, study author Shelley Tworoger said.

View Full Article in:

U.S. News & World Report

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY